ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

NCI’s Schneiderman Reports Result Of Better Treatment, Some Drop In Incidence, Overall Increase As Kennedy Hearings Open

March 9, 1979

Garb Denies He, Panel Said Contract Should Be Primary Funding Mechanism

March 17, 1978

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

ASCO, Komen Begin Initiative To Address Cancer Care Disparities.

October 31, 2008

House Committee Gives NCI Only $6.5 Million Over President’s request

July 28, 1989

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013